Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 2
1998 1
1999 2
2000 1
2001 1
2002 2
2005 1
2008 3
2009 1
2011 2
2012 2
2013 1
2014 3
2015 2
2016 2
2018 1
2019 4
2020 2
2021 5
2022 5
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Spliceosome Mutations in Uveal Melanoma.
Nguyen JQN, Drabarek W, Yavuzyigitoglu S, Medico Salsench E, Verdijk RM, Naus NC, de Klein A, Kiliç E, Brosens E. Nguyen JQN, et al. Among authors: naus nc. Int J Mol Sci. 2020 Dec 15;21(24):9546. doi: 10.3390/ijms21249546. Int J Mol Sci. 2020. PMID: 33333932 Free PMC article. Review.
Is Tissue Still the Issue? The Promise of Liquid Biopsy in Uveal Melanoma.
de Bruyn DP, Beasley AB, Verdijk RM, van Poppelen NM, Paridaens D, de Keizer ROB, Naus NC, Gray ES, de Klein A, Brosens E, Kiliç E. de Bruyn DP, et al. Among authors: naus nc. Biomedicines. 2022 Feb 21;10(2):506. doi: 10.3390/biomedicines10020506. Biomedicines. 2022. PMID: 35203714 Free PMC article. Review.
Uveal Melanoma Patients Have a Distinct Metabolic Phenotype in Peripheral Blood.
de Bruyn DP, Bongaerts M, Bonte R, Vaarwater J, Meester-Smoor MA, Verdijk RM, Paridaens D, Naus NC, de Klein A, Ruijter GJG, Kiliç E, Brosens E; Rotterdam Ocular Melanoma Study Group (ROMS). de Bruyn DP, et al. Among authors: naus nc. Int J Mol Sci. 2023 Mar 7;24(6):5077. doi: 10.3390/ijms24065077. Int J Mol Sci. 2023. PMID: 36982149 Free PMC article.
Ophthalmological Findings in Youths With a Newly Diagnosed Brain Tumor.
Nuijts MA, Stegeman I, van Seeters T, Borst MD, Bennebroek CAM, Buis DR, Naus NC, Porro GL, van Egmond-Ebbeling MB, Voskuil-Kerkhof ESM, Pott JR, Franke NE, de Vos-Kerkhof E, Hoving EW, Schouten-van Meeteren AYN, Imhof SM. Nuijts MA, et al. Among authors: naus nc. JAMA Ophthalmol. 2022 Oct 1;140(10):982-993. doi: 10.1001/jamaophthalmol.2022.3628. JAMA Ophthalmol. 2022. PMID: 36107418 Free PMC article.
Identification of Early-Onset Metastasis in SF3B1 Mutated Uveal Melanoma.
Drabarek W, van Riet J, Nguyen JQN, Smit KN, van Poppelen NM, Jansen R, Medico-Salsench E, Vaarwater J, Magielsen FJ, Brands T, Eussen B, Bosch TPPVD, Verdijk RM, Naus NC, Paridaens D, de Klein A, Brosens E, van de Werken HJG, Kilic E, On Behalf Of The Rotterdam Ocular Melanoma Study Group. Drabarek W, et al. Among authors: naus nc. Cancers (Basel). 2022 Feb 8;14(3):846. doi: 10.3390/cancers14030846. Cancers (Basel). 2022. PMID: 35159112 Free PMC article.
Evaluation of Circulating Tumor DNA as a Liquid Biomarker in Uveal Melanoma.
de Bruyn DP, van Poppelen NM, Brands T, van den Boom SC, Eikenboom E, Wagner A, van Veghel-Plandsoen MM, Geeven G, Beverloo B, van Rij CM, Verdijk RM, Naus NC, Bagger MM, Kiilgaard JF, de Klein A, Brosens E, Kiliç E. de Bruyn DP, et al. Among authors: naus nc. Invest Ophthalmol Vis Sci. 2024 Feb 1;65(2):11. doi: 10.1167/iovs.65.2.11. Invest Ophthalmol Vis Sci. 2024. PMID: 38319670 Free PMC article.
Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma.
Bol KF, van den Bosch T, Schreibelt G, Mensink HW, Keunen JE, Kiliç E, Japing WJ, Geul KW, Westdorp H, Boudewijns S, Croockewit SA, van Rossum MM, de Goede AL, Naus NC, van der Graaf WT, Gerritsen WR, de Klein A, Punt CJ, Figdor CG, Cohen VM, Paridaens D, de Vries IJ. Bol KF, et al. Among authors: naus nc. Ophthalmology. 2016 Oct;123(10):2265-7. doi: 10.1016/j.ophtha.2016.06.027. Epub 2016 Jul 29. Ophthalmology. 2016. PMID: 27476772 Clinical Trial. No abstract available.
FOXD1 Is a Transcription Factor Important for Uveal Melanocyte Development and Associated with High-Risk Uveal Melanoma.
van den Bosch QCC, Nguyen JQN, Brands T, van den Bosch TPP, Verdijk RM, Paridaens D, Naus NC, de Klein A, Kiliç E, Brosens E; Rotterdam Ocular Melanoma Study Group. van den Bosch QCC, et al. Among authors: naus nc. Cancers (Basel). 2022 Jul 28;14(15):3668. doi: 10.3390/cancers14153668. Cancers (Basel). 2022. PMID: 35954332 Free PMC article.
46 results